[1] BURNS KA,LI Y,ARAO Y,et al.Selective mutations in estrogen receptor alpha D-domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms[J].J Biol Chem,2011,286(14):12640-12649.
[2] 范颖,沙立春,李斌.雌激素受体亚型与雌激素依赖性妇科疾病的关系[J].中国妇幼保健,2007,22(7):970-973.
[3] BRODOWSKA A,LASZCZYNSKA M,STARCZEWSKI A,et al.The localization of estrogen receptor alpha and its function in the ovaries of postmenopausal women[J].Folia Histochem Cytobiol,2007,45(4):325-330.
[4] ZAHEDI P,YOGANATHAN R,PIQUETTE-MILLER M,et al.Recent advances in drug delivery strategies for treatment of ovarian cancer[J].Expert Opin Drug Deliv,2012,9(5):567-583.
[5] ZHAN Q,WANG C,NGAI S.Ovarian Cancer Stem Cells:A New target for cancer therapy[J].BioMed Research International,2013,2013:916819.
[6] De STEFANO I,ZANNONI G F,PRISCO M G,et al.Cytoplasmic expression of estrogen receptor beta(ERbeta) predicts poor clinical outcome in advanced serous ovarian cancer[J].Gynecol Oncol,2011,122(3):573-579.
[7] BURGES A,BRUNING A,DANNENMANN C,et al.Prognostic significance of estrogen receptor alpha and beta expression in human serous carcinomas of the ovary[J].Arch Gynecol Obstet,2010,281(3):511-517.
[8] HALON A,NOWAK-MARKWITZ E,MACIEJCZYK A,et al.Loss of estrogen receptor beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patients[J].Anticancer Res,2011,31(2):711-718.
[9] DANNENMANN C,SHABANI N,FRIESE K,et al.The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer,represses ERbeta,and enhances expression of oncogenic cytokine GRO[J].Cancer Biol Ther,2008,7(9):1460-1467.
[10] ZHU J,HUA K,SUN H,et al.Re-expression of estrogen receptor beta inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cells[J].Oncol Rep,2011,26(6):1497-1503.
[11] 田丽媛,赵亚力,韩为东.雌激素受体在卵巢癌发生发展中作用的研究进展[J].国外医学妇产科学分册,2007,34(4):254.
[12] O'DONNELL A J,MACLEOD K G,BURNS D J,et al.Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen[J].Endocr Relat Cancer,2005,12(4):851-866.
[13] HÄRING J,SCHVLER S,LATTRICH C,et al.Role of estrogen receptor β in gynecological cancer[J].Gynecol Oncol,2012,127(3):673-676.
[14] JACKSON K S,BRUDNEY A,HASTINGS J M,et al.The altered distribution of the steroid hormone receptors and the chaperone immunophilin FKBP52 in a baboon model of endometriosis is associated with progesterone resistance during the window of uterine receptivity[J].Reprod Sci,2007,14(2):137-150.
[15] CAVALLINI A,RESTA L,CARINGELLA A M,et al.Involvement of estrogen receptor-related receptors in human ovarian endometriosis[J].Fertil Steril,2011,96(1):102-106.
[16] SMUC T,HEVIR N,RIBIC-PUCELJ M,et al.Disturbed estrogen and progesterone action in ovarian endometriosis[J].Mol Cell Endocrinol,2009,301(1-2):59-64.
[17] WANG C,MAVROGIANIS P A,FAZLEABAS A T.Endometriosis is associated with progesterone resistance in the baboon(Papio anubis) oviduct:evidence based on the localization of oviductal glycoprotein 1(OVGP1)[J].Biol Reprod,2009,80(2):272-278.
[18] KELLERT I M,BOTTERWECK A A,HUVENEERS J A,et al.Trends in incidence of and mortality from uterin e and ovarian cancer in Mid and South Limburg,The Netherlands,1986-2003[J].Eur J Cancer Prey,2009,18(I):85-89.
[19] STRISSEL P L,SWIATEK J,OPPELT P,et al.Transcriptional analysis of steroid hormone receptors in smooth muscle uterine leiomyoma tumors of postmenopausal patients[J].Steroid Biochem Mol Biol,2007,107(1-2):42-47.
[20] JONGEN V,BRIT J,De JONG R,et al.Expression of estrogen receptor-alpha and-beta and progesterone receptor-A and-B in a large cohort of patients with endometrioid endometrial cancer[J].Gynecol Oncol,2009,112:537-42.
[21] MYLONAS I.Prognostic significance cance and clinical importance of estrogen receptor alpha and beta in human endometrioid adenocarcinomas[J].Oncol Rep,2010,24:385-93.
[22] SHAI A,BRAKE T,SOMOZA C,et al.The human papillomavirus E6 oncogene dysregulates the cell cycle and contributes to cervical carcinogenesis through two independent activities[J].Cancer Res,2007,67:1626-1635.
[23] CHUNG S H,WIEDMEYER K,SHAI A,et al.Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer[J].Cancer Res,2008,68:9928-9934.
[24] HERMON T L,MOORE A B,YU L,et al.Estrogen receptor alpha(ERα) phospho-serine-118 is highly expressed in human uterine leiomyomas compared to matched myometrium[J].Virchows Arch,2008,453(6):557-569.
[25] BAKAS P,LIAPIS A,VLAHOPOULOS S,et al.Estrogen receptor alpha and beta in uterine fibroids:a basis for altered estrogen responsiveness[J].Fertil Steril,2008,90(5):1878-1885.
[26] YU L,MOORE AB,DIXON D.Receptor tyrosine kinases and their hormonal regulation in uterine leiomyoma[J].Semin Reprod Med,2010,28(3):250-259.
[27] ZHAO Y,ZHANG W,WANG S.The expression of estrogen receptor isoforms α, β and insulin-like growth factor-Ⅰ in uterine leiomyoma[J].Gynecological Endocrinology,2008,24(10):549-554.
[28] GRINGS A O,LORA V,FERREIRA G D,et al.Protein expression of estrogen receptors α and β and aromatase in myometrium and uterine leiomyoma[J].Gynecol Obestet Invest,2012,73(2):113-117. |